APP
Live / Registered — Registered and renewed (as of 12 Feb 2020)
What this means for you
Registered since 05 Jan 2010. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 05 Jan 2020).
Record
- Serial number
- 77318368
- Registration number
- 3734707
- Mark type
- Design + words
- Filed
- 31 Oct 2007
- Published for opposition
- 04 Nov 2008
- Registered
- 05 Jan 2010
- Next maintenance due
- 05 Jan 2020
- Attorney of record
- Kevin C. Parks
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace elements, vitamins, oncolytics, biological proteins, antibodies, immune-modulators, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; pharmaceuticals for treatment of cancer; pharmaceuticals to treat vascular diseases
- Class 035 — Advertising and business services: Distributorship services, retail pharmaceutical and wholesale ordering services featuring pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace elements, vitamins, micronutrients, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; distributorship and retail ordering services featuring pharmaceuticals for the treatment of cancer, pharmaceuticals to treat vascular diseases and devices for intravenous administration of pharmaceuticals, namely, transfer pins, vials, pumping chamber sets, lubricants, adaptors and tamper resistant seals
Owner
- FRESENIUS KABI USA, LLC, Lake Zurich, IL, US
- APP Pharmaceuticals, LLC, Schaumburg, IL, US
- APP Pharmaceuticals, LLC, Schaumburg, IL, US
- APP Pharmaceuticals, LLC, Schaumburg, IL, US
Prosecution history
- 12 Feb 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 12 Feb 2020 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 12 Feb 2020 — REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
- 12 Feb 2020 — REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
- 12 Feb 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Jan 2020 — TEAS SECTION 8 & 9 RECEIVED
- 05 Jan 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 04 Mar 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Mar 2016 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Mar 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Dec 2015 — TEAS SECTION 8 & 15 RECEIVED
- 25 Mar 2013 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Mar 2013 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Sept 2012 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 05 Jan 2010 — REGISTERED-PRINCIPAL REGISTER